AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Company presents preclinical results from AIDS vaccine program.
2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corporation (NASDAQ:TGEN) announced that it presented positive data in support of its AIDS vaccine program at the 6th Annual Meeting of the American Society of Gene Therapy in Washington, DC.
Studies presented discussed preclinical results that demonstrate the safety profile and robust immune response of the Company's preventive HIV vaccine candidate, tgAAC09, which is based on recombinant adeno-associated viral (rAAV) vector technology. The completion of these studies supports initiation of a Phase I AAV-based AIDS vaccine clinical trial in humans in ...
- U.S. AWARDS $15 MIL TO GEOVAX HIV/AIDS VACCINE PROGRAM.
- Newspaper article from: Biotech Business November 1, 2007 700+ words
...Integrated Preclinical/Clinical AIDS Vaccine Development [IPCAVD] Grant to support its HIV/AIDS vaccine program. This large Grant was awarded...must supply substantial positive AIDS vaccine data to support their application...
- United States awards $15 million grant to GeoVax' HIV/AIDS vaccine program.
- Newspaper article from: BIOTECH Patent News October 1, 2007 700+ words
...Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Grant to support its HIV/AIDS vaccine program. This large Grant was awarded...must supply substantial positive AIDS vaccine data to support their application...
- U.S. Government Awards $15 Million Grant to GeoVax Labs' HIV/AIDS Vaccine...
- Press release article from: PR Newswire September 26, 2007 700+ words
...Integrated Preclinical/Clinical AIDS Vaccine Development [IPCAVD] Grant to support its HIV/AIDS vaccine program. This large Grant was awarded...must supply substantial positive AIDS vaccine data to support their application...
- Targeted Genetics Presents Preclinical Results From AIDS Vaccine Program;...
- Press release article from: PR Newswire June 6, 2003 700+ words
...positive data in support of its AIDS vaccine program today at the 6th Annual Meeting...from Targeted Genetics' AIDS vaccine program will also be presented today...from Targeted Genetics' AIDS vaccine program will also be discussed today...
- Targeted Genetics Announces Promising Preclinical Results from Its AIDS Vaccine...
- Press release article from: PR Newswire April 3, 2003 700+ words
...today announced promising data from its AIDS vaccine preclinical program at the annual Keystone AIDS Vaccine Conference, held in Banff, Alberta...Targeted Genetics, the International AIDS Vaccine Initiative (IAVI) and CCRI are collaborating...
- Targeted Genetics, IAVI and Collaborators Expand Phase I Clinical Trial Program...
- Press release article from: PR Newswire February 7, 2005 700+ words
...the not-for-profit International AIDS Vaccine Initiative (IAVI), the Indian Council...viral vector (rAAV)-based HIV/AIDS vaccine candidate. The trial in India is part...strategy to evaluate AAV-based HIV/AIDS vaccine candidates in a variety of settings...
- Hunt for AIDS vaccine: Slowly things start to move.(Opinion/Editorial)
- Newspaper article from: Manila Bulletin Presse, Richard Ingham Agence France June 24, 2001 700+ words
...and distribution of an AIDS vaccine, the number of products...says the International AIDS Vaccine Initiative (IAVI...in the world has an HIV vaccine program," a US lobbying group, the AIDS Vaccine Advocacy Coalition (AVAC...
- VGX Pharmaceuticals Presents Non-Human Primate Study Data at AIDS Vaccine 2008...
- Press release article from: Business Wire October 15, 2008 700+ words
...PENNVAX[TM] HIV Vaccine Program and its patented CELLECTRA...presentations at the AIDS Vaccine 2008 Conference currently...generated in our HIV vaccine program and the opportunity...at the prestigious AIDS Vaccine 2008 Conference, which...
Source: HighBeam Research, Company presents preclinical results from AIDS vaccine program.